• / Free eNewsletters & Magazine
  • / My Account
Home>Insiders>Michael D, McIntosh

Michael D, McIntosh

  1. Comtech Receives $4.2 Million of Funding for the U.S. Army Sustainment Support of the Blue Force Tracking Program

    Comtech Receives $4.2 Million of Funding for the U.S. Army Sustainment Support of the Blue Force Tracking Program

  2. Humanetics Awarded Patent for Drug That Improves the Effectiveness of Radiation Treatment for Cancer

    Humanetics Awarded Patent for Drug That Improves the Effectiveness of Radiation Treatment for Cancer

  3. LaSalle Hotel Properties Provides Hurricane Irma Impact Update

    LaSalle Hotel Properties Provides Hurricane Irma Impact Update

  4. Deciphera Pharmaceuticals Announces FDA Orphan Drug Designation for DCC-2618 for the Treatment of Glioblastoma Multiforme and Anaplastic Astrocytoma

    Deciphera Pharmaceuticals Announces FDA Orphan Drug Designation for DCC-2618 for the Treatment of Glioblastoma Multiforme and Anaplastic Astrocytoma

  5. Carter’s, Inc. Announces Participation at the Goldman Sachs Global Retailing Conference

    Carter’s, Inc. Announces Participation at the Goldman Sachs Global Retailing Conference

  6. Bristol-Myers Squibb and Pfizer Present Investigational Eliquis® (apixaban) Data for Patients with Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion

    Bristol-Myers Squibb and Pfizer Present Investigational Eliquis® (apixaban) Data for Patients with Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion

1234

©2017 Morningstar Advisor. All right reserved.